The decline of diamonds as a store of wealth is accelerating as low-cost laboratory gems seize more of the market.
The Jade City white paper outlines how their unique platform will kick off a new era of RWA tokenization when it launches later in 2024. The white paper details a totally novel approach to RWA token ...
Black Diamond Therapeutics and Ideaya Biosciences are mulling over registrational trials for their lead assets after ...
Black Diamond Therapeutics reports promising initial Phase 2 data for BDTX-1535 in relapsed EGFR-mutant NSCLC patients. With ...
Black Diamond’s Traverse 3 poles are simplicity refined. The Traverse 3 is a 125cm touring pole in 3 sections, a magical ...
Black Diamond Therapeutics (NASDAQ:BDTX) reported encouraging Phase 2 data for its drug candidate BDTX-1535 in the treatment ...
Black Diamond Therapeutics, Inc. (BDTX) announced positive initial Phase 2 results for BDTX-1535 in patients with relapsed or ...
Shares in Black Diamond Therapeutics rose after the company outlined positive initial data from Phase 2 trials of BDTX-1535, an oral cancer treatment. Shares were up 46% in premarket trading at $6.94.
Webcast to be held Monday, September 23, at 8:00 a.m. ET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback